Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Modum Bad
ClinicalTrials.gov Identifier:
NCT01446172
First received: October 3, 2011
Last updated: April 20, 2012
Last verified: April 2012
  Purpose

While cognitive therapy and exposure therapy are both proven to be effective for panic disorder and/or agoraphobia when outcome is assenssed up to one year after treatment (Gould et al., 1995) the scientific knowledge about long-term course of these disorders is still scanty. Although several long-term outcome studies have been conducted, the quality of these studies has been questioned.

The aim is to conduct a follow-up study of patients with either panic disorder with history of agoraphobia or agoraphobia without history of panic disorder. the patients were treated in a group format at Modum Bad during the years 1989 to 1997. Four subsamples will be included in the study. Subsample 1 (76 patients treated in 1989 and 1990) received combined cognitive and psychodynamic treatment. Subsample 2 and 3 (46 patients treated in 1992 - 1993) were allocated to either cognitive therapy or guided mastery treatment. Subsample 4 (45 patients treated in 1994 - 1996) received cognitive and schema focused therapy.

In the follow-up study the participants will be requested to complete the same self report measures as they completed at intake, discharge and at previous follow-up times. the participants will also be interviewed using the SCID-I and II as they were at the previous assessments.

The present sample is relatively unique in having received pure psychosocial experimental treatments. The very long term efficacy of cognitive therapy relative to behavioural treatmetns for agoraphobia can be evaluated, and the potential moderating effects of personality disorders can be assessed.


Condition
Agoraphobia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Panic Disroder and Agoraphobia

Further study details as provided by Modum Bad:

Estimated Enrollment: 132
Study Start Date: November 2009
Study Completion Date: November 2010
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
cognitive, schema focused, guided mastery, exposure

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients diagnosed with panic disorder with or without agoraphobia and/or agoraphobia without history of panic disorder who have accepted treatment at an inpatient psychiatric hospital

Criteria

Inclusion Criteria:

  • Meet the DSM-IV kriteria for either panic disorder, panic disorder with agoraphobia or agoraphobia

Exclusion Criteria:

  • psychosis
  • dementia
  • substance abuse
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01446172

Locations
Norway
Modum Bad
Vikersund, Norway
Sponsors and Collaborators
Modum Bad
  More Information

No publications provided

Responsible Party: Modum Bad
ClinicalTrials.gov Identifier: NCT01446172     History of Changes
Other Study ID Numbers: Hedley-1
Study First Received: October 3, 2011
Last Updated: April 20, 2012
Health Authority: Norway: Regional Ethics Commitee

Keywords provided by Modum Bad:
Long term outcome

Additional relevant MeSH terms:
Agoraphobia
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 10, 2014